|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 379.80 DKK | +3.43% |
|
-3.51% | -26.61% |
| Mar. 09 | Gubra's partner AbbVie reports positive phase 1 results for ABBV-295 | RE |
| Mar. 06 | Gubra A/S, 2025 Pre Recorded Earnings Call, Feb 27, 2026 |
Insiders
Search
| Feb. 10 | Gubra Appoints Zoë Johnson as Head of Gubra Ventures | CI |
| Jan. 08 | Amylyx Pharmaceuticals, Inc. Announces Nomination of Amx0318 as A Novel, Long-Acting Glp-1 Receptor Antagonist | CI |
| Jan. 05 | Gubra Announces Executive Changes | CI |
| 25-08-12 | Gubra Appoints Successor to Outgoing CEO | MT |
| 25-08-12 | Gubra appoints Markus Rohrwild as CEO | RE |
| 25-08-12 | Gubra A/S Announces CEO Changes | CI |
| 25-04-03 | Monika Lessl Appointed New Chair Of Gubra Board Of Directors | RE |
| 25-04-03 | Gubra A/S Approves Board Changes | CI |
| 25-03-10 | Gubra A/S Announces Board Changes | CI |
| 25-01-15 | Gubra appoints Anne-Marie Levy Rasmussen as COO | FW |
| 25-01-15 | Gubra Appoints Anne-Marie Levy Rasmussen as Chief Operating Officer | CI |
| 24-05-07 | Gubra A/S Announces Management Changes | CI |
| 23-11-01 | Gubra A/S Announces Board Appointments | CI |
No results for this search
Select your edition
All financial news and data tailored to specific country editions
